T1	Participants 15 36	children with autism:
T2	Participants 322 342	children with autism
T3	Participants 548 719	40 consecutive children with autism, whose ages ranged from 2 to 9 years, who were receiving either risperidone or placebo given orally at a dose of 1 mg/day for 6 months.
T4	Participants 922 933	40 children